Cancer Causes & Control

, Volume 21, Issue 12, pp 2137–2147

MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study

  • Anne Kricker
  • Bruce K. Armstrong
  • Chris Goumas
  • Peter Kanetsky
  • Richard P. Gallagher
  • Colin B. Begg
  • Robert C. Millikan
  • Terence Dwyer
  • Stefano Rosso
  • Loraine D. Marrett
  • Nancy E. Thomas
  • Marianne Berwick
  • GEM Study Group
Original paper

Abstract

We investigated whether MC1R genotype modifies the effect of sun exposure on melanoma risk in 1,018 cases with multiple melanomas (MPM) and 1,875 controls with one melanoma (SPM). There was some suggestion that MC1R genotype modified the effect of beach and water activities on MPM risk: ORs were 1.94 (95% CI 1.40–2.70) for any activities for no R variants and 1.39 (95% CI 1.05–1.84) with R variants (R151C, R160W, D294H, and D84E) (p for interaction 0.08). MC1R modification of sun exposure effects appeared most evident for MPM of the head and neck: for early life ambient UV, the OR was 4.23 (95% CI 1.76–10.20) with no R and 1.04 (95% CI 0.40–2.68) with R (p for interaction = 0.01; p for three-way interaction = 0.01). Phenotype modified the effect of sun exposure and MPM in a similar manner. We conclude that MC1R and pigmentary phenotype may modify the effects of sun exposure on melanoma risk on more continuously sun-exposed skin. Possible explanations include that risk may saturate with higher sun sensitivity for melanomas on continuously sun-exposed sites but continue to increase as sun exposure increases with lower sun sensitivity, or that sun-sensitive people adapt their behavior by increasing sun protection when exposed.

Keywords

Melanoma MC1R polymorphism Sun exposure Pigmentary phenotype 

References

  1. 1.
    Holman CD, Armstrong BK (1984) Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 72(2):257–266PubMedGoogle Scholar
  2. 2.
    Kaldor J, Khlat M, Parkin DM, Shiboski S, Steinitz R (1990) Log-linear models for cancer risk among migrants. Int J Epidemiol 19(2):233–239CrossRefPubMedGoogle Scholar
  3. 3.
    Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41(1):45–60CrossRefPubMedGoogle Scholar
  4. 4.
    Rees JL (2003) Genetics of hair and skin color. Annu Rev Genet 37:67–90CrossRefPubMedGoogle Scholar
  5. 5.
    Sturm RA, Teasdale RD, Box NF (2001) Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277(1–2):49–62CrossRefPubMedGoogle Scholar
  6. 6.
    Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA (2005) Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 14(15):2145–2154CrossRefPubMedGoogle Scholar
  7. 7.
    Kanetsky PA, Rebbeck TR, Hummer AJ et al (2006) Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 66(18):9330–9337CrossRefPubMedGoogle Scholar
  8. 8.
    Begg CB, Orlow I, Hummer AJ et al (2005) Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 97(20):1507–1515CrossRefPubMedGoogle Scholar
  9. 9.
    Kricker A, Armstrong BK, Goumas C et al (2007) Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 18(3):295–304CrossRefPubMedGoogle Scholar
  10. 10.
    Begg CB, Hummer AJ, Mujumdar U et al (2006) A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 35(3):756–764CrossRefPubMedGoogle Scholar
  11. 11.
    Galore G, Azizi E, Scope A, Pavlotsky F, Yakobson E, Friedman E (2007) The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients. Melanoma Res 17(2):105–108CrossRefPubMedGoogle Scholar
  12. 12.
    Beaumont KA, Shekar SN, Cook AL, Duffy DL, Sturm RA (2008) Red hair is the null phenotype of MC1R. Hum Mutat 29(8):E88–E94CrossRefPubMedGoogle Scholar
  13. 13.
    Rothman KJ, Greenland S (1998) Modern epidemiology. Lippencott-Raven, PhiladeplhiaGoogle Scholar
  14. 14.
    Cook EF, Goldman L (1989) Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. J Clin Epidemiol 42(4):317–324CrossRefPubMedGoogle Scholar
  15. 15.
    Miettinen OS (1976) Stratification by a multivariate confounder score. Am J Epidemiol 104(6):609–620PubMedGoogle Scholar
  16. 16.
    Landi MT, Kanetsky PA, Tsang S et al (2005) MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 97(13):998–1007CrossRefPubMedGoogle Scholar
  17. 17.
    Matichard E, Verpillat P, Meziani R et al (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41(2):e13CrossRefPubMedGoogle Scholar
  18. 18.
    Fargnoli MC, Altobelli E, Keller G, Chimenti S, Hofler H, Peris K (2006) Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res 16(2):175–182CrossRefPubMedGoogle Scholar
  19. 19.
    Kanetsky PA, Panossian S, Elder DE et al (2010) Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? CancerGoogle Scholar
  20. 20.
    Han J, Kraft P, Colditz GA, Wong J, Hunter DJ (2006) Melanocortin 1 receptor variants and skin cancer risk. Int J Cancer 119(8):1976–1984CrossRefPubMedGoogle Scholar
  21. 21.
    Dwyer T, Stankovich JM, Blizzard L et al (2004) Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 159(9):826–833CrossRefPubMedGoogle Scholar
  22. 22.
    Stratigos AJ, Dimisianos G, Nikolaou V et al (2006) Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 126(8):1842–1849CrossRefPubMedGoogle Scholar
  23. 23.
    Armstrong BK (2004) How sun exposure causes skin cancer: an epidemiological perspective. In: Hill D, Elwood JMJ, English DR (eds) Prevention of skin cancer. Kluwer, DordrechtGoogle Scholar
  24. 24.
    Fears TR, Bird CC, Guerry D et al (2002) Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res 62(14):3992–3996PubMedGoogle Scholar
  25. 25.
    Westerdahl J, Ingvar C, Masback A, Jonsson N, Olsson H (2000) Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV—a carcinogenicity. Br J Cancer 82(9):1593–1599CrossRefPubMedGoogle Scholar
  26. 26.
    Han J, Kraft P, Nan H et al (2008) A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet 4(5):e1000074CrossRefPubMedGoogle Scholar
  27. 27.
    Nan H, Kraft P, Qureshi AA et al (2009) Genome-wide association study of tanning phenotype in a population of European ancestry. J Invest Dermatol 129(9):2250–2257CrossRefPubMedGoogle Scholar
  28. 28.
    Gudbjartsson DF, Sulem P, Stacey SN et al (2008) ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40(7):886–891CrossRefPubMedGoogle Scholar
  29. 29.
    Bishop DT, Demenais F, Iles MM et al (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41(8):920–925CrossRefPubMedGoogle Scholar
  30. 30.
    Nan H, Kraft P, Hunter DJ, Han J (2009) Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int J Cancer 125(4):909–917CrossRefPubMedGoogle Scholar
  31. 31.
    Duffy DL, Zhao ZZ, Sturm RA, Hayward NK, Martin NG, Montgomery GW (2010) Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J Invest Dermatol 130(2):520–528CrossRefPubMedGoogle Scholar
  32. 32.
    Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC (2003) Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95(11):806–812CrossRefPubMedGoogle Scholar
  33. 33.
    Lucas RM, Ponsonby AL, Dear K et al (2009) Associations between silicone skin cast score, cumulative sun exposure, and other factors in the Ausimmune Study: a multicenter Australian study. Cancer Epidemiol Biomarkers Prev 18(11):2887–2894CrossRefPubMedGoogle Scholar
  34. 34.
    English DR, Armstrong BK, Kricker A (1998) Reproducibility of reported measurements of sun exposure in a case–control study. Cancer Epidemiol Biomarkers Prev 7(10):857–863PubMedGoogle Scholar
  35. 35.
    Kricker A, Vajdic CM, Armstrong BK (2005) Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 14(10):2427–2432CrossRefPubMedGoogle Scholar
  36. 36.
    Karagas MR, Zens MS, Nelson HH et al (2007) Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol 165(6):719–726CrossRefPubMedGoogle Scholar
  37. 37.
    Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41(14):2040–2059CrossRefPubMedGoogle Scholar
  38. 38.
    Begg CB, Hummer A, Mujumdar U et al (2004) Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 15(9):957–965PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Anne Kricker
    • 1
  • Bruce K. Armstrong
    • 1
  • Chris Goumas
    • 1
  • Peter Kanetsky
    • 2
  • Richard P. Gallagher
    • 3
  • Colin B. Begg
    • 4
  • Robert C. Millikan
    • 5
  • Terence Dwyer
    • 6
  • Stefano Rosso
    • 7
  • Loraine D. Marrett
    • 8
  • Nancy E. Thomas
    • 9
  • Marianne Berwick
    • 10
  • GEM Study Group
  1. 1.Sydney School of Public HealthThe University of SydneySydneyAustralia
  2. 2.University of PennsylvaniaPhiladelphiaUSA
  3. 3.British Columbia Cancer AgencyVancouverCanada
  4. 4.Memorial Sloan-Kettering Cancer CenterNew YorkUSA
  5. 5.Department of Epidemiology, School of Public HealthUniversity of North CarolinaChapel HillUSA
  6. 6.Royal Children’s HospitalVictoriaAustralia
  7. 7.Piedmont Cancer RegistryCentre for Epidemiology and Prevention in Oncology in PiedmontTurinItaly
  8. 8.Cancercare OntarioTorontoCanada
  9. 9.Department of Dermatology, Lineberger Comprehensive Cancer CenterUniversity of North CarolinaChapel HillUSA
  10. 10.University of New MexicoAlbuquerqueUSA

Personalised recommendations